« Back to Record
Citation APA

Bajetta, E., Di Leo, A., Zampino, M. G., Sertoli, M. R., Comella, G., Barduagni, M., Giannotti, B., Queirolo, P., Tribbia, G., Bernengo, M. G. R., Menichetti, E. T., Palmeri, S., Russo, A., Cristofolini, M., Erbazzi, A., Fowst, C., Criscuolo, D., Bufalino, R., Zilembo, N., & Cascinelli, N. (1994). Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma. Journal of clinical oncology, 12(4), 806-811.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/229776

Bajetta, E., Di Leo, A., Zampino, M. G., Sertoli, M. R., Comella, G., Barduagni, M., Giannotti, B., Queirolo, P., Tribbia, G., Bernengo, M. G. R., Menichetti, E. T., Palmeri, S., Russo, A., Cristofolini, M., Erbazzi, A., Fowst, C., Criscuolo, D., Bufalino, R., Zilembo, N., & Cascinelli, N. (1994). Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma. Journal of clinical oncology, 12(4), 806-811.